✦ LIBER ✦

Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease

✍ Scribed by Ingebjørg Seljeflot; Serena Tonstad; Ingvar Hjermann; Harald Arnesen

Book ID: 119435478
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 133 KB
Volume: 162
Category: Article
ISSN: 0021-9150
DOI: 10.1016/s0021-9150(01)00696-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced expression of soluble markers of

Reduced expression of soluble markers of endothelial dysfunction after 1 year treatment with atorvastatin and simvastatin in patients with coronary heart disease

✍ I Seljeflot; S Tonstad; I Hjermann; R Kleve; H Arnesen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Markers of inflammation, thrombosis and

Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment

✍ D. Baldassarre; B. Porta; M. Camera; M. Amato; M. Arquati; B. Brusoni; C. Fioren 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Effects on soluble markers of endothelia

Effects on soluble markers of endothelial dysfunction after 4.5 years treatment with ACE-inhibitor ramipril in patients with coronary heart disease (HOPE substudy)

✍ E.M. Hjerkinn; I. Seljeflot; Å. Reikvam; H. Arnesen 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB

1P-0017 Hypotriglyceridemic and non-lipi

1P-0017 Hypotriglyceridemic and non-lipid effects of atorvastatin and simvastatin therapy in coronary heart disease patients with combined hyperlipidemia and type 2 diabetes mellitus

✍ Vasutina, E.; Metelskaya, V.A.; Akhmedzhanov, N.M.; Ratnikova, L.A.; Oganov, R.G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Atorvastatin Reduces Expression of the C

Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease

✍ L. Reinares, A. Figueredo, A. Rueda, J. C. Pontes, A. Rodríguez, M. Ruiz-Yagüe, 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 136 KB

Comparison of Efficacy and Safety of Ato

Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged <65 Versus ≥65 Years With Coronary Heart Disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] Study)

✍ Matti J. Tikkanen; Ingar Holme; Nilo B. Cater; Michael Szarek; Ole Faergeman; Jo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 205 KB